Quetiapine Fumarate Tablets Market - Global Forecast 2026-2032

The quetiapine fumarate tablets market remains a central pillar in psychiatric care, with demand shaped by evolving provider requirements, regulatory pressures, and changing procurement strategies. Senior decision-makers face a dynamic marketplace where access, consistency, and performance are critical to sustainable growth and competitive standing.

Market Snapshot: Growth and Strategic Shifts

The Quetiapine Fumarate Tablets Market grew from USD 2.47 billion in 2025 to USD 2.65 billion in 2026. It is expected to continue expanding at a CAGR of 6.77%, reaching USD 3.92 billion by 2032. Market leadership increasingly hinges on operational excellence, supply reliability, and the ability to meet stringent buyer and regulatory expectations across varied geographies.

Scope & Segmentation

Therapeutic Indications: Schizophrenia, bipolar disorder, adjunctive therapy in major depressive disorder.
Release Profiles: Immediate-release, extended-release formulations to match diverse clinical and workflow requirements.
Strength Variants: Tailored dosage strengths support individualized patient management and titration needs.
Packaging Formats: Bulk bottles, unit-dose and specialized packs, with features aligning to high-throughput and traceability priorities.
End-User Settings: Inpatient psychiatric facilities, long-term care institutions, retail and mail-order pharmacies, and behavioral health centers.
Distribution Pathways: Institutional buying groups, large chain pharmacies, independent outlets, and direct sales to healthcare organizations.
Regions: Americas; Europe, Middle East & Africa; Asia-Pacific, each with distinct regulatory and procurement environments.
Technologies: Pharmacy automation, e-prescribing systems, medication adherence tracking, serialization, and traceability technology.

Key Takeaways for Senior Stakeholders

Multi-source qualification and strong supplier relationships are rising in importance as buyers prioritize resilience and continuity over pure acquisition cost.
Payers and institutional customers are placing emphasis on adherence-friendly packaging, clear labeling, and inventory transparency to reduce the risk of dispensing errors and therapy gaps.
Digitalization, including barcode-enabled tracking and pharmacy automation, is elevating operational standards and reshaping both distribution and patient experience expectations.
Procurement and contracting strategies increasingly reward companies demonstrating proactive risk management, disciplined change control, and consistent audit readiness.
Segmented customer needs—from acute care to retail—demand tailored supply chain, packaging, and service commitments to maintain loyalty and status as a preferred supplier.
Regional compliance and procurement nuances necessitate adaptable go-to-market strategies aligned with local regulations, reimbursement models, and trade routes.

Tariff Impact: Navigating New Cost Variables

The introduction of United States tariffs in 2025 introduces new complexities across the quetiapine tablet supply chain. Manufacturers and distributors with cross-border input dependencies may face increased costs and operational complexity. Buyers will experience tighter negotiations and may see shifts in supplier priorities, while diversified sourcing and robust scenario planning emerge as essential resilience strategies. Organizations capable of transparent communication and rapid operational adaptation are expected to build stronger trust among partners and mitigate volatility risks.

Methodology & Data Sources

This report is grounded in a triangulated methodology, combining regulatory review, in-depth interviews across the value chain, and operational validation to deliver actionable, reliable insights. Primary research is supplemented by consistent discussion guides and cross-checked with regulatory filings and procurement data to ensure relevance for market strategy and executive decision-making.

Why This Report Matters

Provides decision-focused analysis to help mitigate supply and regulatory risks in a mature, heavily scrutinized market.
Identifies pragmatic strategies for aligning portfolios, packaging, and service levels with evolving procurement and reimbursement models globally.
Supports investment in operational resilience, compliance discipline, and differentiated customer relationships to sustain competitive positioning.

Conclusion

Executives operating in the quetiapine fumarate tablets space must prioritize resilience, transparency, and compliance to succeed. By anticipating shifts in procurement, digitalization, and tariff-related pressures, market leaders can sustain access and trust among increasingly discerning buyers.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Quetiapine Fumarate Tablets Market, by Product Type

8.1. Branded
8.1.1. Original Formulation
8.1.2. Reformulation
8.2. Generic
8.2.1. Authorized Generic
8.2.2. Unbranded Generic

9. Quetiapine Fumarate Tablets Market, by Indication

9.1. Bipolar Mania
9.1.1. Bipolar I
9.1.2. Bipolar II
9.2. Major Depressive Disorder
9.3. Schizophrenia
9.3.1. Acute
9.3.2. Chronic

10. Quetiapine Fumarate Tablets Market, by Dosage Form

10.1. Extended Release
10.2. Immediate Release

11. Quetiapine Fumarate Tablets Market, by Distribution Channel

11.1. Hospital Pharmacy
11.1.1. Non-Teaching Hospital
11.1.2. Teaching Hospital
11.2. Online Pharmacy
11.3. Retail Pharmacy
11.3.1. Chain Pharmacy
11.3.2. Independent Pharmacy

12. Quetiapine Fumarate Tablets Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Quetiapine Fumarate Tablets Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Quetiapine Fumarate Tablets Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Quetiapine Fumarate Tablets Market
16. China Quetiapine Fumarate Tablets Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Accord Healthcare Limited
17.6. Alkem Laboratories Ltd.
17.7. AstraZeneca PLC
17.8. Aurobindo Pharma Limited
17.9. Cheplapharm Arzneimittel GmbH
17.10. Cipla Limited
17.11. Dr. Reddy's Laboratories Ltd.
17.12. Hetero Labs Ltd.
17.13. Intas Pharmaceuticals Ltd.
17.14. Lupin Limited
17.15. Luye Pharma Group Limited
17.16. Pharmathen Investments Group
17.17. Sandoz International GmbH
17.18. Sun Pharmaceutical Industries Limited
17.19. Teva Pharmaceutical Industries Ltd.
17.20. Torrent Pharmaceuticals Limited
17.21. Viatris Inc.

List of Figures

FIGURE 1. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES QUETIAPINE FUMARATE TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA QUETIAPINE FUMARATE TABLETS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY ORIGINAL FORMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY ORIGINAL FORMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY ORIGINAL FORMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY REFORMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY REFORMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY REFORMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY AUTHORIZED GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY AUTHORIZED GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY AUTHORIZED GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY UNBRANDED GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY UNBRANDED GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY UNBRANDED GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR I, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR I, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR I, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR II, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR II, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR II, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY ACUTE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY ACUTE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY ACUTE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY CHRONIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY CHRONIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY CHRONIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY EXTENDED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY EXTENDED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY IMMEDIATE RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY IMMEDIATE RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY NON-TEACHING HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY NON-TEACHING HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY NON-TEACHING HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY TEACHING HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY TEACHING HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY TEACHING HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 123. EUROPE QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. EUROPE QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. EUROPE QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 126. EUROPE QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 127. EUROPE QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 128. EUROPE QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 129. EUROPE QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 130. EUROPE QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 131. EUROPE QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. EUROPE QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 133. EUROPE QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 145. AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 147. AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 148. AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 149. AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 150. AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 151. AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 152. AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 153. AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 154. AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 155. AFRICA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. ASEAN QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. ASEAN QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 170. ASEAN QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 171. ASEAN QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 172. ASEAN QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 173. ASEAN QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 174. ASEAN QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 175. ASEAN QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 176. ASEAN QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 177. ASEAN QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 178. ASEAN QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 179. GCC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GCC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 181. GCC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 182. GCC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 183. GCC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 184. GCC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 185. GCC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 186. GCC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 187. GCC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. GCC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 189. GCC QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 201. BRICS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. BRICS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 203. BRICS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 204. BRICS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 205. BRICS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 206. BRICS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 207. BRICS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 208. BRICS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 209. BRICS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. BRICS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 211. BRICS QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 212. G7 QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. G7 QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 214. G7 QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 215. G7 QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 216. G7 QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 217. G7 QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 218. G7 QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 219. G7 QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 220. G7 QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 221. G7 QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 222. G7 QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 223. NATO QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. NATO QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 225. NATO QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 226. NATO QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 227. NATO QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 228. NATO QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 229. NATO QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 230. NATO QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 231. NATO QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 232. NATO QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 233. NATO QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES QUETIAPINE FUMARATE TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 246. CHINA QUETIAPINE FUMARATE TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 247. CHINA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 248. CHINA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 249. CHINA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 250. CHINA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 251. CHINA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY BIPOLAR MANIA, 2018-2032 (USD MILLION)
TABLE 252. CHINA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2032 (USD MILLION)
TABLE 253. CHINA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 254. CHINA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 255. CHINA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 256. CHINA QUETIAPINE FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Quetiapine Fumarate Tablets market report include:

Accord Healthcare Limited
Alkem Laboratories Ltd.
AstraZeneca PLC
Aurobindo Pharma Limited
Cheplapharm Arzneimittel GmbH
Cipla Limited
Dr. Reddy's Laboratories Ltd.
Hetero Labs Ltd.
Intas Pharmaceuticals Ltd.
Lupin Limited
Luye Pharma Group Limited
Pharmathen Investments Group
Sandoz International GmbH
Sun Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd.
Torrent Pharmaceuticals Limited
Viatris Inc.

Table Information

Report Attribute	Details
No. of Pages	185
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 2.65 Billion
Forecasted Market Value ( USD ) by 2032	$ 3.92 Billion
Compound Annual Growth Rate	6.7%
Regions Covered	Global
No. of Companies Mentioned	18

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Growth and Strategic Shifts

Scope & Segmentation

Key Takeaways for Senior Stakeholders

Tariff Impact: Navigating New Cost Variables

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Quetiapine Intermediate Chemicals Market Outlook 2026-2034: Market Share, and Growth Analysis

Tenofovir Disoproxil Fumarate Tablets Market - Global Forecast 2026-2032

Vonoprazan Fumarate Tablets Market - Global Forecast 2025-2030

Quetiapine (CAS 111974-69-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

Imipramine Hydrochloride Tablet Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application